IQVIA (IQV) P/E (2013 - 2026)
IQVIA (IQV) P/E from May 9, 2013 to Jul 21, 2026. The TTM IQVIA (IQV) P/E is 24.64. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of IQVIA (IQV)
| Year | P/E | Change |
|---|---|---|
| 2026 | 24.64 | -12.88% |
| 2025 | 28.29 | +9.72% |
| 2024 | 25.78 | -32.45% |
| 2023 | 38.16 | +16.98% |
| 2022 | 32.62 | -41.56% |
| 2021 | 55.82 | -54.56% |
| 2020 | 122.86 | -22.35% |
| 2019 | 158.23 | +79.47% |
| 2018 | 88.17 | -86.96% |
| 2017 | 675.94 | +2858.77% |
| 2016 | 22.85 | +5.23% |
| 2015 | 21.71 | +4.69% |
| 2014 | 20.74 | -19.59% |
| 2013 | 25.79 | N/A |
Comparison IQVIA (IQV) P/E with competitors
IQVIA (IQV) P/E is 24.64.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -95.74% |
| MBAI | CheckCap Ltd | 1.71 | -93.05% |
| FONR | Fonar Corp | 15.48 | -37.19% |
| QGEN | Qiagen NV | 20.03 | -18.71% |
| DGX | Quest Diagnostics Inc | 22.47 | -8.80% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -3.13% |
| A | Agilent Technologies Inc | 26.96 | +9.40% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | +27.95% |
| MTD | Mettler-Toledo International Inc | 32.45 | +31.69% |
| MEDP | Medpace Holdings Inc | 32.55 | +32.10% |
| DHR | Danaher Corp | 38.55 | +56.46% |
| IDXX | Idexx Laboratories Inc | 40.58 | +64.67% |
| ILMN | Illumina Inc | 44.12 | +79.05% |
| RVTY | Revvity Inc | 52.68 | +113.79% |
| VCYT | Veracyte Inc | 53.71 | +117.98% |
| ICLR | Icon Plc | 57.45 | +133.15% |
| SHC | Sotera Health Company | 74.08 | +200.65% |
| WAT | Waters Corp | 102.79 | +317.13% |